What Is 3-deoxy-D-manno-octulosonate aldolase

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 15, 2026

Quick Answer: 3-deoxy-D-manno-octulosonate aldolase (KDO aldolase) is an enzyme that catalyzes the reversible cleavage of 3-deoxy-D-manno-octulosonate (KDO) into pyruvate and D-arabinose 5-phosphate. It plays a critical role in lipopolysaccharide (LPS) biosynthesis in Gram-negative bacteria, particularly in the inner membrane of Escherichia coli.

Key Facts

3-deoxy-D-manno-octulosonate aldolase catalyzes a reversible reaction with a Km of ~0.15 mM for KDO
The enzyme is essential for lipopolysaccharide biosynthesis in Gram-negative bacteria like Escherichia coli
KDO aldolase was first purified and characterized in 1987 from Escherichia coli K-12
It belongs to the class I aldolase family and uses a Schiff base mechanism involving a lysine residue
Structural studies show the enzyme functions as a homotetramer with a molecular weight of approximately 148 kDa

Overview

3-deoxy-D-manno-octulosonate aldolase, commonly known as KDO aldolase, is a bacterial enzyme involved in the biosynthesis of lipopolysaccharides (LPS), a major component of the outer membrane in Gram-negative bacteria. This enzyme catalyzes the reversible aldol cleavage of 3-deoxy-D-manno-octulosonate (KDO) into pyruvate and D-arabinose 5-phosphate, a reaction critical for the formation of the inner core region of LPS.

Due to its specificity and essential role in bacterial cell wall integrity, KDO aldolase has become a target for antimicrobial drug development. The enzyme is not found in humans, making it an attractive candidate for selective inhibition without harming host cells.

Substrate specificity: The enzyme exhibits high specificity for KDO, with a Km of approximately 0.15 mM, indicating strong binding affinity under physiological conditions.
Reaction reversibility: The reaction it catalyzes is fully reversible, allowing it to function in both catabolic and anabolic pathways depending on metabolic demand.
Localization: In Escherichia coli, KDO aldolase is located in the cytoplasmic compartment, where it participates in early stages of LPS assembly.
Gene identification: The gene encoding this enzyme in E. coli is kdOA, located at 35.8 minutes on the genetic map.
Enzyme class: It belongs to the class I aldolase family, which utilizes a Schiff base intermediate formed with a conserved lysine residue.

How It Works

The mechanism of 3-deoxy-D-manno-octulosonate aldolase involves precise molecular interactions that enable the cleavage and synthesis of KDO. Each step is tightly regulated to maintain metabolic flux in LPS biosynthesis.

Catalytic residue: A conserved lysine residue (Lys172) forms a Schiff base with the carbonyl group of KDO, stabilizing the reaction intermediate during cleavage.
Reaction mechanism: The enzyme follows a retro-aldol mechanism, breaking the C6–C7 bond of KDO to yield pyruvate and D-arabinose 5-phosphate in under 10 milliseconds.
Quaternary structure: Functional KDO aldolase exists as a homotetramer with subunits of ~37 kDa each, totaling ~148 kDa.
pH optimum: Maximum activity occurs at pH 7.5, consistent with the cytoplasmic environment of Gram-negative bacteria.
Metal independence: Unlike many aldolases, KDO aldolase does not require metal ions for catalytic activity, relying solely on amino acid residues.
Thermal stability: The enzyme retains activity up to 45°C but denatures rapidly above 50°C, limiting its function to mesophilic conditions.

Comparison at a Glance

Below is a comparison of KDO aldolase with other class I aldolases based on structural and functional properties:

Enzyme	Organism	Substrate	Molecular Weight (kDa)	Reaction Type
KDO aldolase	Escherichia coli	3-deoxy-D-manno-octulosonate	148	Reversible aldol cleavage
Fuctose-1,6-bisphosphate aldolase	Rabbit muscle	Fructose-1,6-bisphosphate	150	Reversible cleavage to G3P and DHAP
Neuraminidase aldolase	Influenza virus	Sialic acid	80	Hydrolysis, not aldol cleavage
Transaldolase	Human	Sedoheptulose-7-phosphate	34	Transfer of dihydroxyacetone moiety
DAH7P synthase	E. coli	DAHP	180	First step in aromatic amino acid pathway

While KDO aldolase shares mechanistic similarities with other class I aldolases, its exclusive role in LPS biosynthesis and absence in mammals distinguish it as a unique target for antibiotic development. Its tetrameric structure and lack of metal dependence further differentiate it from eukaryotic counterparts.

Why It Matters

Understanding KDO aldolase has significant implications for microbiology, infectious disease treatment, and drug discovery. Its bacterial specificity makes it a model for designing narrow-spectrum antibiotics.

Antibiotic target: Inhibitors of KDO aldolase could disrupt LPS formation, leading to cell lysis in Gram-negative pathogens like Salmonella and Pseudomonas.
Drug specificity: Because humans lack this enzyme, drugs targeting it are less likely to cause off-target toxicity.
Biotechnological use: Engineered variants are used in synthetic biology to produce rare sugars and KDO analogs for vaccine development.
Resistance prevention: Targeting LPS biosynthesis may reduce the likelihood of rapid antibiotic resistance compared to traditional drugs.
Vaccine adjuvants: KDO-containing molecules are being explored as immune stimulants due to their recognition by Toll-like receptors.
Diagnostic potential: Detection of KDO aldolase activity could serve as a biomarker for Gram-negative bacterial infections in clinical settings.

As antibiotic resistance rises globally, enzymes like KDO aldolase offer promising alternatives for next-generation therapeutics. Continued research into its structure and function may unlock new strategies for combating multidrug-resistant bacteria.